Alnylam Pharmaceuticals

20 followers

‌

Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.

Industries

Pharmaceutical

Headquarters

Cambridge, United States

Employees

1,001-5,000

Links

Org chart

Yvonne Greenstreet

CEO

Yvonne Greenstreet

Collapse

Pushkal Garg

Chief Medical Officer

Jeff Poulton

CFO

Vasant Jadhav

Chief Technology Officer

Tolga Tanguler

CCO

Kevin Fitzgerald

Chief Scientific Officer

Evan Lippman

Chief Corporate Development & Strategy Officer

Kelley Boucher

Chief Human Resource Officer

Timothy Maines

Chief Technical Operations & Quality Officer

Christine Lindenboom

Chief Corporate Communications Officer

Robert Hesslein

Chief Legal Officer & Corporate Secretary

Kasha Witkos

SVP, International Region Head

Julie Milner

VP Head Of International Regulatory Affairs

Priya Sankar

Vice President, General Counsel, Global Research & Development

Arianna Greco

Svp, General Counsel Commercial

Brett Budzinski

Senior Vice President, General Counsel, Corporate And Governance, Corporate Secretary

Steve Bossone

Senior Vice President, Chief Patent Counsel

Marcia Anderegg

Vp, Head Of Corporate Legal

Elliot Mandel

Vice President, Legal Operations

Jake Carleton

Legal Director

Teams

+51

Leadership Team

54 members

+48

Research and Development

51 members

+17

Clinical Operations

20 members

+12

Finance and Accounting

15 members

+12

Human Resources and Talent Management

15 members

Data Analytics and Engineering

10 members

Similar companies

Omnicell

21 followers

West Pharmaceutical Services

7 followers

PCI Pharma Services

6 followers

Cambrex

3 followers

Incyte

15 followers

CONMED

2 followers

ProPharma Group

2 followers

EVERSANA

5 followers

Amplity Health

1 follower

Capsugel Holdings US, Inc.

1 follower

Masimo

8 followers

Explore companies